Where Global Innovation
and Capital Meet

Storm’s series A continues to resound with investors

May 20, 2019 • Callum Cyrus

Cambridge's cancer drug spinout Storm Therapeutics convinced its existing investors to join new participant Seroba Life Sciences for a second extension that brought its series A total to $38.2m.

Storm Therapeutics, a UK-based developer of epigenetic cancer therapies spun out of University of Cambridge, today extended its series A round to £30m ($38.2m) with a third tranche sized at $17.8m.
Cambridge Innovation Capital (CIC), the university’s affiliate patient capital fund, took part in the extension alongside commercialisation firm IP Group and venture firm Seroba Life Sciences.
M Ventures, Pfizer Ventures and Taiho Ventures – respective investment subsidiaries of pharmaceutical firms Merck Group, Pfizer and Taiho Pharmaceutical –…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

More universities adopt investor-friendly IP spinout terms

Academic institutions are taking new approaches to transferring intellectual property rights of university research in a bid to help spinouts attract investors.

Imec.xpand closes Fund II at $320m

The deep tech venture firm has surpassed its original goal by $50m and more than doubled its assets under management to $455m.

New fund to target University of Arkansas startups

Venture firm 46VC’s Dickson & Main Fund I will invest in companies associated with the university or the local Arkansas ecosystem.

Events

GCV Institute: Landing the Value of Corporate Venturing

May 6 -
May 9, 2024
Online

Find out more All events

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.